3Beck JT,Hsu SM,Wijdenes J,et al.Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody[J].N Engl J Med,1994,330(9):602-605. 被引量：1
4Curioni S,D'Amico M,Quartagno R,et al.Castleman's disease with nephrotic syndrome,amyloidosis and autoimmune manifestations[J].Nephrol Dial Transplant,2001,16(7):1475-1478. 被引量：1
5Frizzera G.Castleman's disease and related disorders[J].Semin Diag Pathol,1988,5(4):346-364. 被引量：1
6Keven K,Nergizoglu G,Ates K,et al.Remission of nephrotic syndrome after removal of localized Castleman's disease.[J]Am J Kidney Dis,2000,35(6):1207-1211. 被引量：1
7Karie S,Izzedine H,Beaufils H,et al.Lymphadenopathy and proteinuria[J].Nephrol Dial Transplant,2004,19(3):739-741. 被引量：1
8Frizzera G, Peterson B A, Bayrd E D, et al. A systemic lymphoprolifer- ative disorder with morphologic features of Castleman's disease: clini- cal findings and clinicopathological correlations in 15 patients. J Clin Oncol, 1985,3 : 1202. 被引量：1
9KarieS, IzzedineH, BeaufilsH, et al. Lymphadenopathy and proteinuria. Nephrol Dial Transplant,2004,19(3) :739. 被引量：1
10Keven K, NergizogluG, AtesK, et al. Remission of nephrotic syndrome after removal of localized Castleman' s disease. Am J Kidney Dis, 2000,35(6) : 1207. 被引量：1
